| Model Number |
EVOLUTR-34-US |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Valvular Insufficiency/ Regurgitation (4449); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/06/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that approximately 8 years and 2 months following the implant of a transcatheter aortic valve, the valve failed due to an unspecified cause.The patient is being evaluated for a potential valve-in-valve procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b1.Adverse event and product problem.B2.Outcome attributed to adverse event.B5.A second paragraph was added.H1.The original information indicated the event was a reportable malfunction.Additional information indicates that intervention was required.The event is now a reportable serious injury.Additional codes.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately 8 years and 2 months following the implant of this transcatheter aortic valve (tav), the valve failed due to an unspecified cause.The patient was evaluated for a potential tav-in-tav procedure.Additional information was received to report a non-medtronic transcatheter valve was implanted five days after the failure was identified.
|
| |
|
Event or Problem Description
|
|
It was reported that approximately (b)(6) following the implant of this transcatheter aortic valve (tav), the valve failed due to an unspecified cause.The patient was evaluated for a potential tav-in-tav procedure.Additional information was received to report a non-medtronic transcatheter valve was implanted five days after the failure was iden tified.Additional information was received that the valve failure mode was central regurgitation of an unknown severity.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated: b5, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|